Martin Samuel Bates

CIK 00017090241 companyHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001709024

Recent Transactions

49 trades

Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2026-06-25+93,000→ 93,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2026-01-02−4,817→ 58,815 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2026-01-02$10.38/sh+4,817→ 32,942 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2025-06-05+81,000→ 81,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-14$9.02/sh+3,201→ 28,329 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-14$10.38/sh+16,968→ 45,297 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-14−16,968→ 63,632 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-06-14$35.42/sh−17,172→ 28,125 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-06-14−3,201→ 0 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2024-06-13+81,000→ 81,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-05-30−25,000→ 80,600 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$10.38/sh+25,000→ 60,128 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-05-30$34.05/sh−35,000→ 25,128 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2024-01-02−10,750→ 0 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2024-01-02$2.78/sh+10,750→ 35,128 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2023-06-15+80,000→ 80,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-12$2.78/sh+13,671→ 41,925 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-12$36.76/sh−14,261→ 27,664 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-12$35.38/sh−2,065→ 25,599 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-12$34.62/sh−1,221→ 24,378 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2022-08-12−3,876→ 3,201 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-12$9.02/sh+3,876→ 28,254 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2022-08-12−13,671→ 10,750 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-11$9.02/sh+2,453→ 26,831 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2022-08-11$37.04/sh−2,453→ 24,378 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2022-08-11−2,453→ 7,077 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2022-06-16+85,000→ 85,000 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-23$9.02/sh+3,250→ 30,128 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-23−3,250→ 9,530 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-12-23−3,750→ 24,421 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-23$2.78/sh+3,750→ 33,878 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-12-23$42.00/sh−9,500→ 24,378 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-15−3,250→ 12,780 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (Right to Buy)
2021-11-15−3,750→ 28,171 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-15$43.92/sh−7,452→ 28,926 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-15$42.27/sh−2,048→ 26,878 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-15$2.78/sh+3,750→ 36,378 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-11-15$9.02/sh+3,250→ 32,628 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-08-10$45.25/sh−2,056→ 18,981 total
Sale
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-08-10$45.25/sh−682→ 29,378 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2021-08-10−10,302→ 16,030 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-08-10$2.78/sh+11,079→ 30,060 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option
2021-08-10−11,079→ 31,921 total
Exercise/Conversion
Celldex Therapeutics, Inc.$CLDX
Common Stock
2021-08-10$9.02/sh+10,302→ 21,037 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2021-06-17+85,000→ 85,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2020-06-18+105,600→ 105,600 total
Purchase
Celldex Therapeutics, Inc.$CLDX
Common Stock, par value $0.001 per share
2020-06-09$3.05/sh+9,750→ 10,735 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2019-06-19+43,000→ 43,000 total
Award
Celldex Therapeutics, Inc.$CLDX
Incentive Stock Option (right to buy)
2018-06-13+395,000→ 395,000 total

Companies

Celldex Therapeutics, Inc.
SVP AND CFO
$CLDX

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov